18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
    9.
    发明申请
    18-Methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter 失效
    18-甲基-19-去甲-17-孕-4-烯-21,17-碳内酯,以及含有后者的药物制剂

    公开(公告)号:US20060252737A1

    公开(公告)日:2006-11-09

    申请号:US11321449

    申请日:2005-12-30

    IPC分类号: A61K31/58 C07J19/00

    CPC分类号: C07J19/00

    摘要: This invention describes the new 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones of general formula I in which Z means an oxygen atom, two hydrogen atoms, a grouping ═NOR or ═NNHSO2R, whereby R is a hydrogen atom or a straight-chain or branched-chain alkyl group with 1 to 4 or 3 to 4 carbon atoms, R4 is a hydrogen atom, a halogen atom, a methyl group, or a trifluoromethyl group, R6 and/or R7 can be in α- or β-position, and, independently of one another, mean a straight-chain or branched-chain alkyl group with 1 to 4 or 3 to 4 carbon atoms, or R6 means a hydrogen atom, and R7 means an α- or β-position, straight-chain or branched-chain alkyl group with 1 to 4 or 3 to 4 carbon atoms, or R6 and R7 each mean a hydrogen atom, or R6 and R7 together mean an α- or β-position methylene group or an additional bond. The new compounds have gestagenic and anti-mineralocorticoid action and are suitable for the production of pharmaceutical preparations, for example for oral contraception and the treatment of pre-, peri- and post-menopausal symptoms.

    摘要翻译: 本发明描述了通式I的新的18-甲基-19-去甲-17-孕甾-4-烯-21,17-碳内酯,其中Z表示氧原子,两个氢原子,-NOR或-NNHSO- R 2是氢原子或具有1至4或3至4个碳原子的直链或支链烷基,R 4是氢原子 ,卤素原子,甲基或三氟甲基,R 6和/或R 7可以是α-或β-位,并且独立地为一个 另一个是指具有1至4或3至4个碳原子的直链或支链烷基,或R 6表示氢原子,R 7表示 具有1至4或3至4个碳原子的α-或β-位的直链或支链烷基,或R 6和R 7各自表示 氢原子或R 6和R 7一起是指α-或β-位亚甲基或另外的键。 新化合物具有孕激素和抗盐皮质激素的作用,并且适用于制备药物制剂,例如用于口服避孕和治疗绝经前,绝经期和绝经后症状。